DGCI Current Affairs, GK & News
Vice President launched ‘Vaccinate India Programme’
Vice President of India, M. Venkaiah Naidu, launched “Vaccinate India Programme” on August 24, 2021. On the occasion, he appealed to the people to strictly follow COVID-19 norms. Key points This programme was organised by Give India Foundation and Sustainable Goals Coordination Centre in Bengaluru. It was launched under CSR in association with Planning Department ..
Month: Current Affairs - August, 2021
Category: India Nation & States Current Affairs
Topics: COVID-19 • COVID-19 vaccination • DGCI • Vaccinate India Programme • Vice President M. Venkaiah Naidu
DCGI approves ZyCoV-D vaccine for Emergency Use Authorization
The Drug Controller General of India (DGCI) has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization. Key Points According to Ministry of Science and Technology, ZyCoV-D vaccine is the world’s first and India’s indigenously developed DNA-based vaccine for COVID-19. It will be administered to humans including children and adults aged 12 years and ..
Month: Current Affairs - August, 2021
Category: Science & Technology Current Affairs
Topics: COVID-19 • COVID-19 vaccine • DGCI • Drug Controller General of India • Emergency Use Authorisation • ZyCov-D • Zydus Cadila
Zydus drug Virafin gets DCGI nod
The Drug Controller General of India recently provided “Restricted Emergency Use Approval” for the use of “Virafin”. Virafin is used to treat Hepatitis B and C. Now it is to be used to treat moderate COVID-19 infections. About Virafin A single dose of Virafin during the early stage of infection, will help COVID-19 patients recover ..
Month: Current Affairs - April, 2021
Category: Economy & Banking Current Affairs
Topics: COVID-19 vaccine • DGCI • Drug Controller General of India • Drugs and Cosmetics Act 1940 • Eukaryotes • medical devices rules • RT-PCR • VIrafin • ZyCov-D • Zydus Cadila
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..
Month: Current Affairs - January, 2021
Category: Science & Technology Current Affairs
Topics: Bharat Biotech • COVAXIN • Covishield • DGCI • Emergency Use Authorisation • HGCO19 • ICMR • SPUTNIK V • ZyCov-D